Dr. Benjamin B. Bedford, MD

Dr. Bedford practices at SurgiCare of Manhattan in New York, New York.

Dr. Bedford's NPI, 1124260799, was assigned on March 29, 2009. Dr. Bedford graduated from University of Rochester Medical Center in 2004. Dr. Bedford holds New York license 246678.

Dr. Bedford's primary practice is SurgiCare of Manhattan, at 800 Second Ave, New York, NY 10017. The practice phone is (212) 867-0609.

Dr. Bedford's primary practice is SurgiCare of Manhattan in New York, New York. Dr. Bedford is also affiliated with Lenox Hill Hospital. The medical group on file is NY Orthopedics. Dmand AI also links Dr. Bedford to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bedford practices, 5 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Bedford's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Bedford is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Bedford's licenses on file in 3 states: New York, New Jersey and Alabama.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, bursitis, chest wall injury, enthesopathy in arms, enthesopathy in foot or ankle and fluid in a joint among the conditions Dr. Bedford treats.

CMS data shows 10,324 Medicare services from Dr. Bedford across 14 procedure codes in 2024, for 428 Medicare patients. Medicare paid $185,786 for them.

CMS counts 428 Medicare patients who saw Dr. Bedford in 2024. The largest group is 75 to 84, with 196 patients. 75% of them have arthritis, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bedford's median patient age at 39, with 47% women.

In 2024, Dr. Bedford wrote 209 Medicare Part D claims for 120 patients. 99% of them were for generic drugs. CMS names the drug for 178 of them, across 6 drugs with 11 or more claims each, at $736 in total drug cost. In 2023, CMS named 100 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Bedford for performance year 2024, reported individually. Dr. Bedford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bedford as offering telehealth. CMS counts 15 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Bedford, more than 55% of the clinicians it reports for that procedure.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Bedford, published from 2015 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Anterior Cruciate Ligament Reconstruction. Dr. Bedford has published most often in Am J Sports Med. Dr. Bedford's most frequent co-authors are Stephen J. Nicholas, MD, Steven J. Lee, MD and John Steven Andrachuk, MD.

Dmand AI links Dr. Bedford to 1 clinical trial. Conditions studied include Pain, Postoperative and Postoperative Complications.

CMS Open Payments shows 461 general payments to Dr. Bedford from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 25% of the total. Arthrex, Inc. paid the most, $60,298.

Dr. Bedford graduated from University of Rochester Medical Center in 2004. Dr. Bedford is a member of AAOS.

Dr. Bedford is in network with 13 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.